Symbols

ZVSA(Delisted)

ZyVersa Therapeutics·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 0

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ZVSA

Zyversa Therapeutics, Inc.

A company that developing biopharmaceuticals for inflammatory and renal diseases

Industry

Established Date

03/17/2021

Listing Date

02/10/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.zyversa.com

Security Type

Common stock

Office address

2200 N. Commerce Pkwy. Suite 208, Weston, Florida 33326

Business

Introduction

ZyVersa Therapeutics, Inc., was incorporated in Delaware on March 17, 2021. The Company is a clinical-stage biopharmaceutical company that utilizes proprietary technology to develop drugs for patients with chronic kidney disease or inflammatory diseases with high unmet medical needs.

Company Financials

EPS

ZVSA has released its 2025 Q3 earnings. EPS was reported at -2.56, versus the expected -0.25, missing expectations. The chart below visualizes how ZVSA has performed over recent quarters, highlighting trends in earnings surprises.